Effect of Lifestyle Intervention on the Occurrence of Metabolic Syndrome and its Components in the Finnish Diabetes Prevention Study
- Pirjo Ilanne-Parikka, MD (pirjo.ilanneparikka{at}diabetes.fi)1,,2,
- Johan G. Eriksson, MD, PhD3,,4,
- Jaana Lindström, PhD3,
- Markku Peltonen, PhD3,
- Sirkka Aunola, PhD5,
- Helena Hämäläinen, MD, PhD6,
- Sirkka Keinänen-Kiukaanniemi, MD, PhD7,,8,,9,
- Mauri Laakso, MD7,,8,,10,
- Timo T. Valle, MD3,
- Jorma Lahtela, MD, PhD11,
- Matti Uusitupa, MD, PhD12 and
- Jaakko Tuomilehto, MD, PhD on behalf of the Finnish Diabetes Prevention Study Group3,,4
- 1 Finnish Diabetes Association, The Diabetes Center, Tampere, Finland
- 2 Pirkanmaa Hospital District, Department of Research Administration, Tampere, Finland
- 3 National Public Health Institute, Department of Health Promotion and Chronic Disease Prevention, Diabetes Unit, Helsinki, Finland
- 4 University of Helsinki, Department of Public Health, Helsinki, Finland
- 5 National Public Health Institute, Department of Health and Functional Capacity, Laboratory for Population Research, Turku, Finland
- 6 Social Insurance Institution, Research Department, Turku, Finland
- 7 University of Oulu, Department of Public Health Science and General Practice, Oulu, Finland
- 8 Oulu Deaconess Institute, Department of Sport Medicine, Oulu, Finland
- 9 Oulu Health Centre, Oulu, Finland
- 10 Oulu University Hospital, Unit of General Practice, Oulu, Finland
- 11 Tampere University Hospital, Department of Internal Medicine, Tampere, Finland
- 12 University of Kuopio, Department of Public Health and Clinical Nutrition, Kuopio, Finland
Abstract
Objective: The aim of this secondary analysis of the Finnish Diabetes Prevention Study (DPS) was to assess the effects of a lifestyle intervention on metabolic syndrome and its components.
Research Design and Methods: 522 middle-aged overweight men and women with impaired glucose tolerance were randomized into an individualized lifestyle intervention group or into a standard care control group in the DPS. The National Cholesterol Education Program criteria were used for the definition of the metabolic syndrome.
Results: At the end of the study with a mean follow-up of 3.9 years we found a significant reduction in the prevalence of metabolic syndrome in the intervention group compared to the control group (OR of 0.62; 95% CI 0.40–0.95) as well in the prevalence of abdominal obesity (OR 0.48; 95% CI 0.28–0.81).
Conclusions: The results suggest that lifestyle intervention may also reduce risk of cardiovascular diseases in long run.
Conclusions: ClinicalTrials.gov ID: NCT00518167
Footnotes
-
- Received August 15, 2007.
- Accepted December 24, 2007.
- Copyright © American Diabetes Association














